Roumen Nakov
Impact in
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
-
- Blood Pressure and Hypertension Studies
- Atrial Fibrillation Management and Outcomes
Papers in
- Oncology 12
- Neutropenia and Cancer Infections 11
-
- Biosimilars and Bioanalytical Methods 5
- Co-authors
- Lars C. Borris (1 shared paper)Michael R. Lassen (1 shared paper)Vijay V. Kakkar (3 shared papers)H.K. Breddin (3 shared papers)V. Hach-Wunderle (1 shared paper)Egon Pfarr (1 shared paper)Frank Misselwitz (2 shared papers)Edelgard Lindhoff‐Last (1 shared paper)
- Journals
- Annals of Oncology (5 papers)British Journal of Clinical Pharmacology (2 papers)Blood (2 papers)Future Oncology (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- GermanyUnited StatesRussia
In The Last Decade
Roumen Nakov
25 papers receiving 854 citations
Peers
Comparison fields: 5 of 75
- Internal Medicine 331
- Cardiology and Cardiovascular Medicine 264
- Hematology 98
- Emergency Medicine 63
- Oncology 173
Countries citing papers authored by Roumen Nakov
This map shows the geographic impact of Roumen Nakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roumen Nakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roumen Nakov more than expected).
Fields of papers citing papers by Roumen Nakov
This network shows the impact of papers produced by Roumen Nakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roumen Nakov. The network helps show where Roumen Nakov may publish in the future.
Co-authors
The 25 scholars most cited alongside Roumen Nakov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 159 | |
| 2 | 2002 | 152 | |
| 3 | 2002 | 144 | |
| 4 | 2002 | 98 | |
| 5 | 2015 | 66 | |
| 6 | 2018 | 46 | |
| 7 | 2002 | 37 | |
| 8 | 2016 | 34 | |
| 9 | 2016 | 30 | |
| 10 | 2009 | 27 | |
| 11 | Staurosporine counteracts the phorbol ester-induced enhancement of neurotransmitter release in hippocampus. | 1989 | 17 |
| 12 | 2018 | 16 | |
| 13 | 2000 | 14 | |
| 14 | 1990 | 13 | |
| 15 | 2003 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2017 | 10 | |
| 18 | 2014 | 9 | |
| 19 | 2017 | 6 | |
| 20 | 2014 | 5 |
About Roumen Nakov
Roumen Nakov is a scholar working on Oncology, Immunology, Internal Medicine, Cardiology and Cardiovascular Medicine and Genetics, having authored 26 papers that have together received 913 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (11 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Biosimilars and Bioanalytical Methods (5 papers), Blood disorders and treatments (4 papers), Atrial Fibrillation Management and Outcomes (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Internal Medicine (331 citations), Cardiology and Cardiovascular Medicine (264 citations), Hematology (98 citations), Emergency Medicine (63 citations) and Oncology (173 citations). Roumen Nakov has collaborated with scholars based in Germany, United States and Russia. Frequent co-authors include Lars C. Borris, Michael R. Lassen, Vijay V. Kakkar, H.K. Breddin, V. Hach-Wunderle, Egon Pfarr, Frank Misselwitz, Edelgard Lindhoff‐Last, Rupert Bauersachs and Kimberly Blackwell. Their work appears in journals such as Annals of Oncology, British Journal of Clinical Pharmacology, Blood, Future Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.